戴納基 DYN 深滬

等待開盤 09-20 09:30:00 美东时间

36.41

+2.070

+6.03%

華盛通

立即下載

最高37.08
今開35.06
成交量 243.19万股
最低 34.87
昨收 34.34
總市值 29.84亿
52周最高 47.45
市盈率 ^靜 --
換手率 2.97%
52周最低 6.40
委比 -80.29%
總股本 8195.81万
歷史最高 47.45
量比 2.46
振幅 6.44%
歷史最低 4.30
每手 1
風險率 11.81%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股周涨跌榜 | 业绩大放异彩！蔚来周涨逾24%，Q3交付指引超预期；疫苗公司Vaxcyte周飙涨38%

业绩大放异彩！蔚来周涨逾24%，Q3交付指引超预期；安全性比肩辉瑞！疫苗公司Vaxcyte周飙涨38%；FYBR周涨23%，Verizon欲斥现金200亿美元收购>>

09-07 11:41
Oppenheimer Reiterates Outperform on Dyne Therapeutics, Maintains $55 Price Target

Oppenheimer analyst Francois Brisebois reiterates Dyne Therapeutics (NASDAQ:DYN) with a Outperform and maintains $55 price target.

09-04 01:52
快讯 | 戴纳基股票在公司发布肌肉疾病药物早期中期研究数据后，在盘前下跌29.5%。

Dyne Therapeutics Shares Down 29.5% Premarket After Co Reports Early-Mid-Stage ...

09-03 20:02
Dyne Therapeutics Q2 2024 GAAP EPS $(0.70) Beats $(0.72) Estimate

Dyne Therapeutics (NASDAQ:DYN) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(0.72) by 2.78 percent. This is a 35.19 percent increase over losses of $(1.08) per share from

08-13 05:19
美股牛股 | 医疗平台HIMS飙升27%，公司推出平价减肥针剂；越南电动车商VinFast升近30%

医疗平台HIMS飙升27%，公司推出减肥注射剂GLP-1，每针价格较诺和诺德的Wegovy低85%；越南电动车商VinFast升近30%；Q1业绩超预期，Wix.com涨23.8%>>

05-21 18:49
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on...

05-20 23:37
Market-Moving News for May 20th

PTCT: 27% | PTC Therapeutics Announces European Commission Returns Translarna Opinion to CHMP For Re-evaluation NKGN: 81% | NKGen Biotech Announces Its Safety Review Committee Has Cleared Co.'s

05-20 20:37
Recap: Dyne Therapeutics Q4 Earnings

Dyne Therapeutics (NASDAQ:DYN) reported its Q4 earnings results on Tuesday, Mar...

03-05 20:40
美股周涨跌榜 | 生物技术公司Vera周内涨超102%！次新股CG Oncology上市累涨超84%

Vera 周涨超102%，肾脏药物试验数据良好；次新股CG Oncology上市累涨超84%，公司为开发膀胱癌溶瘤免疫疗法的生物技术公司>>

01-27 17:00
'Drug Developer Dyne Therapeutics Weigh Options After Takeover Interest' -Bloomberg

https://www.bloomberg.com/news/articles/2024-01-26/dyne-therapeutics-said-to-weigh-options-amid-takeover-interest?cmpid=socialflow-twitter-business&utm_content=business&utm_campaign=socialflow-organic&utm_med

01-27 03:50

派息除權日	每股總股息	派息日期
2002-05-30	0.08	2002-06-17
2002-02-27	0.08	2002-03-15
2001-11-29	0.08	2001-12-17
2001-08-29	0.08	2001-09-17
2001-05-29	0.08	2001-06-15
2001-02-27	0.08	2001-03-15
2000-11-29	0.08	2000-12-15
2000-08-29	0.08	2000-09-15
2000-05-26	0.15	2000-06-15
2000-02-24	0.04	2000-03-31
1999-12-01	0.01	1999-12-21
1999-09-01	0.01	1999-09-21
1999-06-01	0.01	1999-06-28
1999-03-04	0.01	1999-03-26
1998-12-01	0.01	1998-12-21
1998-09-01	0.01	1998-09-21
1998-05-28	0.01	1998-06-22
1998-03-09	0.01	1998-03-27
1997-12-01	0.01	1997-12-19
1997-08-22	0.01	1997-09-16
1997-05-21	0.01	1997-06-16
1997-02-13	0.01	1997-03-05
1996-11-27	0.01	1996-12-16
1996-07-25	0.01	1996-09-03
1996-05-16	0.01	1996-06-04
1996-03-21	0.01	1996-04-09
1995-12-14	0.01	1996-01-02
1995-09-21	0.01	1995-10-10
1995-06-16	0.01	1995-07-05
1995-03-01	0.01	1995-03-21
1994-12-01	0.01	1994-12-21
1994-08-31	0.01	1994-09-21
1994-06-01	0.01	1994-06-21
1994-03-01	0.01	1994-03-21
1984-10-03	0.66	1984-11-01
1984-07-03	0.66	1984-08-01
1984-04-04	0.66	1984-05-01
1984-01-04	0.66	1984-02-01
1983-10-03	0.62	1983-11-01
1983-07-05	0.62	1983-08-01
1983-04-05	0.62	1983-05-02
1983-01-04	0.62	1983-02-01
1982-10-04	0.62	1982-11-01
1982-07-02	0.62	1982-08-02
1982-04-02	0.62	1982-05-01
1982-01-05	0.62	1982-02-01
1981-10-05	0.60	1981-11-02
1981-07-06	0.60	1981-08-01
1981-04-06	0.60	1981-05-01
1981-01-05	0.60	1981-02-02
1980-10-06	0.60	1980-11-01
1980-07-03	0.60	1980-08-01
1980-04-02	0.57	1980-05-01
1980-01-03	0.57	1980-01-31
1979-10-02	0.57	1979-10-31
1979-07-02	0.57	1979-07-31
1979-04-03	0.57	1979-04-30
1979-01-03	0.57	1979-01-31
1978-10-02	0.57	1978-10-31
1978-07-02	0.57	1978-07-31
1978-04-03	0.57	1978-04-30
1978-01-03	0.57	1978-01-31
1977-10-02	0.55	1977-10-31
1977-06-30	0.55	1977-07-31
1977-04-03	0.55	1977-05-01

公司名稱	戴纳基
行業分類	电力
業務描述	Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

戴納基 DYN 深 滬

36.41

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

戴納基 DYN 深滬